Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith McCrae

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Cleveland Clinic Journal of Medicine|June 3, 2011
Immune thrombocytopenia: no longer 'idiopathic'Keith McCrae
Journal of Thrombosis and Thrombolysis|August 17, 2014
Over-testing for heparin induced thrombocytopenia in hospitalized patientsShruti Chaturvedi, Ruhail Kohli, Keith McCrae
Gynecologic Oncology|December 13, 2002
Arterial thrombosis in a gynecologic oncology patient: evaluation and managementAndrew E Green, Keith McCrae, Peter G Rose
Platelets|January 28, 2009
Acute profound thrombocytopenia with second exposure to eptifibatide associated with a strong antibody reactionShariff Attaya, Yogendra Kanthi, Richard Aster, et al.
Current Cancer Drug Targets|December 8, 2004
Extracellular tropomyosin: a novel common pathway target for anti-angiogenic therapyFernando Doñate, Keith McCrae, David E Shaw, et al.
Aesthetic Surgery Journal|December 17, 2008
Von Willebrand disease: screening, diagnosis, and managementAli Totonchi, Yashar Eshraghi, Daniel Beck, et al.
Research and Practice in Thrombosis and Haemostasis|December 17, 2025
The Patient-Reported Outcomes Measurement Information System perspective of adults with long-standing atypical hemolytic uremic syndromeAnne Hubben, Jenna Brown, Linda Burke, et al.
Cleveland Clinic Journal of Medicine|December 16, 2020
Update to coagulopathy in COVID-19: Manifestations and managementSimon R Mucha, Siddharth Dugar, Keith McCrae, et al.
Cleveland Clinic Journal of Medicine|May 16, 2020
Coagulopathy in COVID-19: Manifestations and managementSimon R Mucha, Siddharth Dugar, Keith McCrae, et al.
Cleveland Clinic Journal of Medicine|November 24, 2020
In Reply: COVID-19 coagulopathySimon R Mucha, Siddharth Dugar, Keith McCrae, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Cleveland Clinic Journal of Medicine|June 3, 2011
Immune thrombocytopenia: no longer 'idiopathic'Keith McCrae
Journal of Thrombosis and Thrombolysis|August 17, 2014
Over-testing for heparin induced thrombocytopenia in hospitalized patientsShruti Chaturvedi, Ruhail Kohli, Keith McCrae
Gynecologic Oncology|December 13, 2002
Arterial thrombosis in a gynecologic oncology patient: evaluation and managementAndrew E Green, Keith McCrae, Peter G Rose
Platelets|January 28, 2009
Acute profound thrombocytopenia with second exposure to eptifibatide associated with a strong antibody reactionShariff Attaya, Yogendra Kanthi, Richard Aster, et al.
Current Cancer Drug Targets|December 8, 2004
Extracellular tropomyosin: a novel common pathway target for anti-angiogenic therapyFernando Doñate, Keith McCrae, David E Shaw, et al.
Aesthetic Surgery Journal|December 17, 2008
Von Willebrand disease: screening, diagnosis, and managementAli Totonchi, Yashar Eshraghi, Daniel Beck, et al.
Research and Practice in Thrombosis and Haemostasis|December 17, 2025
The Patient-Reported Outcomes Measurement Information System perspective of adults with long-standing atypical hemolytic uremic syndromeAnne Hubben, Jenna Brown, Linda Burke, et al.
Cleveland Clinic Journal of Medicine|December 16, 2020
Update to coagulopathy in COVID-19: Manifestations and managementSimon R Mucha, Siddharth Dugar, Keith McCrae, et al.
Cleveland Clinic Journal of Medicine|May 16, 2020
Coagulopathy in COVID-19: Manifestations and managementSimon R Mucha, Siddharth Dugar, Keith McCrae, et al.
Cleveland Clinic Journal of Medicine|November 24, 2020
In Reply: COVID-19 coagulopathySimon R Mucha, Siddharth Dugar, Keith McCrae, et al.
Pageof 4